These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 38401002)
1. PXMP4 promotes gastric cancer cell epithelial-mesenchymal transition via the PI3K/AKT signaling pathway. Li W; Dong X; Wan Z; Wang W; Zhang J; Mi Y; Li R; Xu Z; Wang B; Li N; He G Mol Biol Rep; 2024 Feb; 51(1):350. PubMed ID: 38401002 [TBL] [Abstract][Full Text] [Related]
2. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
3. LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway. Hu J; Wang M; Yang Y; Xing Y; Li S Immunopharmacol Immunotoxicol; 2022 Oct; 44(5):719-731. PubMed ID: 35736813 [No Abstract] [Full Text] [Related]
4. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related]
5. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway. Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300 [TBL] [Abstract][Full Text] [Related]
6. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling. Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429 [TBL] [Abstract][Full Text] [Related]
7. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546 [TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells. Zhu J; Wen K Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652 [TBL] [Abstract][Full Text] [Related]
10. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131 [TBL] [Abstract][Full Text] [Related]
11. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway. Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766 [TBL] [Abstract][Full Text] [Related]
13. ACTL8 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Signaling Pathway. Yu W; Zhang Q; Ali M; Chen B; Sun Q; Wang D Dig Dis Sci; 2024 Oct; 69(10):3786-3798. PubMed ID: 39322809 [TBL] [Abstract][Full Text] [Related]
14. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034 [TBL] [Abstract][Full Text] [Related]
15. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway. Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138 [TBL] [Abstract][Full Text] [Related]
16. TASP1 Promotes Proliferation and Migration in Gastric Cancer via EMT and AKT/P-AKT Pathway. Wan XM; Zhou XL; Du YJ; Shen H; Yang Z; Ding Y J Immunol Res; 2021; 2021():5521325. PubMed ID: 34012990 [TBL] [Abstract][Full Text] [Related]
17. GRSF1 promotes tumorigenesis and EMT-mediated metastasis through PI3K/AKT pathway in gastric cancer. Wang B; Wang L; Lu Y; Liang W; Gao Y; Xi H; Chen L Biochem Biophys Res Commun; 2021 May; 555():61-66. PubMed ID: 33813277 [TBL] [Abstract][Full Text] [Related]
18. Glaucocalyxin a prevents hypoxia-induced epithelial-mesenchymal transition in human gastric cancer cells through the PI3K/Akt signaling pathway. Zhou X; Ma W; Li X; Xu J J Recept Signal Transduct Res; 2022 Apr; 42(2):109-116. PubMed ID: 33307912 [TBL] [Abstract][Full Text] [Related]
19. miR-107 regulates growth and metastasis of gastric cancer cells via activation of the PI3K-AKT signaling pathway by down-regulating FAT4. Wang L; Li K; Wang C; Shi X; Yang H Cancer Med; 2019 Sep; 8(11):5264-5273. PubMed ID: 31297980 [TBL] [Abstract][Full Text] [Related]
20. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression. Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]